logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5829.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Export All Citations
Copyright © Médecins Sans Frontières
v2.1.5829.produseast1
Showing 1 - 17 of 17 Items
Showing 1 - 17 of 17 Items
Citations
  • Download citations in various formats (CSV, BibTeX, EndNote) for use in reference managers and bibliographies.
  • Current Page (17)
  • CSV
  • BibTeX
  • EndNote
  • All Results (17)
  • CSV
  • BibTeX
  • EndNote
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Prevalence of high-risk human papillomavirus types among women aged 30–49 years in the Chuy region, Kyrgyzstan

Kozukeev T, EM O, Ciglenecki I, Wachira E, Tenizbaeva A,  et al.
2026-01-02 • Infectious Agents and Cancer
2026-01-02 • Infectious Agents and Cancer

INTRODUCTION

Human papillomavirus (HPV) is a leading cause of cervical cancer globally. High-risk (HR) HPV types HPV16 and 18 are responsible for 70% of cases. ...

Journal Article
|
Research
Conference Material
|
Poster

The field performance of hepatitis E diagnostics during an outbreak in Bentiu, South Sudan

Koyuncu A, Nesbitt R, Alvarez C, 
Conference Material
|
Poster

Dry blood spots as a practical alternative for confirming hepatitis E

Azman AS, Nesbitt R, Alvarez C, Asilaza KV, Wamala J,  et al.
2025-05-22 • MSF Scientific Days International 2025
Journal Article
|
Research
Journal Article
|
Research
Journal Article
|
Research
Conference Material
|
Slide Presentation
Conference Material
|
Abstract
Conference Material
|
Poster
Conference Material
|
Abstract
Conference Material
|
Poster
Conference Material
|
Poster
Conference Material
|
Slide Presentation
Conference Material
|
Abstract
Conference Material
|
Slide Presentation
Journal Article
|
Research

Task sharing for the management of non-communicable diseases in a humanitarian setting: An innovative approach in a low-middle income country (LMIC)

Doumit M, Masri S, Ciglenecki I, Albela M
2025-12-01 • Public Health in Practice
2025-12-01 • Public Health in Practice

ABSTRACT

The World Health Organization (WHO) defines task shifting as the balanced reallocation of tasks from highly experienced professionals to those with mor...

Asilaza KV, 
Wamala J, 
et al.
2025-05-22 • MSF Scientific Days International 2025
2025-05-22 • MSF Scientific Days International 2025
2025-05-22 • MSF Scientific Days International 2025

High confidence and demand for hepatitis E vaccine during an outbreak in Bentiu, South Sudan: A qualitative study

Koyuncu A, Asilaza KV, Rumunu J, Wamala J, Gitahi P,  et al.
2025-03-06 • PLOS Global Public Health
2025-03-06 • PLOS Global Public Health

In 2021 in response to an outbreak of hepatitis E in Bentiu internally displaced persons camp the South Sudanese Ministry of Health with support from Médecins Sans Frontières implemen...

The effectiveness of two doses of recombinant hepatitis E vaccine in response to an outbreak in Bentiu, South Sudan: a case–control and bias indicator study

Nesbitt RC, Kinya Asilaza V, Alvarez C, Gitahi P, Nkemenang P,  et al.
2025-01-08 • Lancet Infectious Diseases
2025-01-08 • Lancet Infectious Diseases

BACKGROUND

Hepatitis E virus (HEV) is a leading cause of acute viral hepatitis, particularly in Asia and Africa, where HEV genotypes 1 and 2 are prevalen...

Safety of hepatitis E vaccine in pregnancy: an emulated target trial following a mass reactive vaccination campaign in Bentiu internally displaced persons camp, South Sudan

Nesbitt RC, Azman AS, Asilaza VK, Edwards JK, Gitahi P,  et al.
2024-11-01 • Lancet Global Health
2024-11-01 • Lancet Global Health

Safety of hepatitis E vaccine in pregnancy: emulating a target trial following a mass reactive vaccination campaign in South Sudan

Nesbitt R, Azman AS, Asilaza VK, Edwards JK, Nkemenang P,  et al.
2024-05-16 • MSF Scientific Day International 2024
2024-05-16 • MSF Scientific Day International 2024

Safety of hepatitis E vaccine in pregnancy: emulating a target trial following a mass reactive vaccination campaign in South Sudan

Nesbitt R, Azman AS, Asilaza VK, Edwards JK, Nkemenang P,  et al.
2024-05-16 • MSF Scientific Day International 2024
2024-05-16 • MSF Scientific Day International 2024

INTRODUCTION

Hepatitis E causes high mortality among pregnant women, with case fatality risks over 30% and adverse fetal outcomes. There is an evidence gap on the safety of the ...

Risk factors for mortality among patients with suspected cholera treated in MSF-supported cholera treatment facilities in Bauchi State, Nigeria

Garcia Naranjo A, Chamman K, Gandi AY, Baba Aminu I, Maigari IM,  et al.
2023-06-07 • MSF Scientific Day International 2023
2023-06-07 • MSF Scientific Day International 2023

Two-dose vaccine effectiveness following the first reactive mass vaccination campaign against hepatitis E in Bentiu, South Sudan

Nesbitt RC, Rumunu J, Asilaza VK, Gitahi P, Nkemenang P,  et al.
2023-06-07 • MSF Scientific Day International 2023
2023-06-07 • MSF Scientific Day International 2023
INTRODUCTION
A three-dose recombinant vaccine against hepatitis E, Hecolin, has been licensed for use in China since 2011. While not recommended for routine use due to lack of eviden...

Vaccination coverage and adverse events following immunisation after the first reactive mass vaccination campaign against Hepatitis E in Bentiu, South Sudan

Nesbitt RC, Rumunu J, Asilaza VK, Gitahi P, Nkemenang P,  et al.
2023-06-07 • MSF Scientific Day International 2023
2023-06-07 • MSF Scientific Day International 2023

Evaluating task-sharing for non-communicable disease management in humanitarian settings: lessons learned from MSF’s model of care in Lebanon

Doumit M, Masri S, Beltran I, Incerti A, Ciglenecki I,  et al.
2023-06-07 • MSF Scientific Day International 2023
2023-06-07 • MSF Scientific Day International 2023

Two-dose vaccine effectiveness following the first reactive mass vaccination campaign against Hepatitis E in Bentiu, South Sudan

Nesbitt RC, Rumunu J, Asilaza VK, Gitahi P, Nkemenang P,  et al.
2023-06-07 • MSF Scientific Day International 2023
2023-06-07 • MSF Scientific Day International 2023

Retrospective mortality and prevalence of SARS-CoV-2 antibodies in greater Omdurman, Sudan: population–based cross–sectional survey

Moser W, Hassan Fahal MA, Abualas E, Bedri S, Elsir MT,  et al.
2022-05-09 • MSF Scientific Days International 2022
2022-05-09 • MSF Scientific Days International 2022
INTRODUCTION
In Sudan, since the first Covid-19 case was declared on 13 March 2020, 32,846 confirmed cases were recorded through 10 April 2021. Of these, 72% were registered in Khart...

Retrospective mortality and prevalence of SARS-CoV-2 antibodies in greater Omdurman, Sudan: population–based cross–sectional survey

Moser W, Hassan Fahal MA, Abualas E, Bedri S, Elsir MT,  et al.
2022-05-10 • MSF Scientific Days International 2022
2022-05-10 • MSF Scientific Days International 2022

Differential symptomology of possible and confirmed Ebola virus disease infection in the Democratic Republic of the Congo: a retrospective cohort study

Nsio JM, Ardiet DL, Coulborn RM, Grellety E, Albela M,  et al.
2023-01-01 • Lancet Infectious Diseases
2023-01-01 • Lancet Infectious Diseases
BACKGROUND
In its earliest phases, Ebola virus disease's rapid-onset, high fever, and gastrointestinal symptoms are largely indistinguishable from other infectious illnesses. We aime...